Synthetic Biology-Engineered CAR-iNKT and CAR-γδ T cells for Anticancer Immunotherapy: A Systematic Multi-Modal CRISPR Discovery Approach

• Applicant: Dr. Alexander Biederstädt
• Subject Area: Hematology, Oncology
• Term: since 2026
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 573859978

No abstract available

• DFG Programme: Emmy Noether Independent Research Groups